1.Unusual Renal Tuberculosis Manifested as an Isolated Renal Mass in an Immunocompromised Patient: A Case Report.
Cheol Mok HWANG ; Jeong Kon KIM ; Kyoung Sik CHO
Journal of the Korean Radiological Society 2002;46(2):159-161
Renal tuberculosis commonly involves the urinary tract and results in multifocal fibrosis and stricture. Rarely, it presents as a renal mass with or without urinary tract abnormality. The radiologic features of this rare pseudotumor have not been sufficiently described in the previous literature, and we now report a case of tuberculosis presenting as an isolated renal mass and multiple hepatic nodules without evidence of associated urinary tract abnormality. The condition mimicked malignant neoplastic disease and occurred in a patient who had undergone chemotherapy for leukemia.
Constriction, Pathologic
;
Drug Therapy
;
Fibrosis
;
Humans
;
Immunocompromised Host*
;
Leukemia
;
Tuberculosis
;
Tuberculosis, Renal*
;
Urinary Tract
2.A case of holoprosencephaly.
Jin Eun HYUN ; Eun Hee PARK ; Hee Young JEON ; Whwa Jin BYEUN ; Young Mok HWANG ; Yeon Jin KIM ; Cheol Soo KIM
Journal of the Korean Pediatric Society 1991;34(12):1712-1716
No abstract available.
Holoprosencephaly*
3.CT Findings of Bronchogenic Cyst.
Hyun Cheol CHO ; Yong Woo LEE ; Mi Soo HWANG ; Kil Ho CHO ; Woo Mok BYUN ; Jae Ho CHO ; Jae Chun CHANG
Yeungnam University Journal of Medicine 1995;12(2):226-236
We studied to evaluate CT characteristics of bronchogenic cysts. We retrospectively evaluated CT of 11 patients with pathologically proved bronchogenic cyst. Precontrast and postcontrast CT scan was performed in all. We analyzed CT with viewpoints of location, size, attenuation on pre- and postcontrast scan, and calcification. Three of 11 bronchogenic cysts were intrapulmonary in location and eight were located in the mediastinum. Two of 3 intrapulmonary bronchogenic cysts were located in the right lower lobe, and the remaining one was left lower lobe. Intrapulmonary bronchogenic cysts ranged from 6cm to 12cm in diameter (average, 9.7 cm). On Cr, intrapulmonary bronchogenic cysts appeared as thin-wall air cyst, homogenous water attenuation and soft tissue attenuation with air bubble respectively. Mediastinal bronchogenic cysts were located in posterior mediastinum(n=5), superior mediastinum(n=2), middle mediastinum(n=1) respectively. These cysts ranged in size from 3cm to 8cm in diameter (average, 5.0 cm). On CT, five showed homogenous water attenuation, two soft tissue attenuation similar to that of muscle, one air-fluid level. Calcification or contrast enhancement was not detected in any cases. On operative findings, all of intrapulmonary bronchogenic cysts contained dirty pus-like material and all of mediastinal bronchogenic cysts contained whitish or yellowish mucus material. Bronchogenic cysts showed homogenous water density in many cases, homogenous soft tissue density, air-fluid level and air-filled cyst. The constellation of CT findings may be helpful in the diagnosis and
Bronchogenic Cyst*
;
Diagnosis
;
Humans
;
Mediastinum
;
Mucus
;
Retrospective Studies
;
Tomography, X-Ray Computed
;
Water
4.Usefulness of CT Fluoroscopy-guided Percutaneous Needle Biopsy in the Presence of Pneumothorax During Biopsy.
Dong Hyun O ; Young Jun CHO ; Yong Sung PARK ; Cheol Mok HWANG ; Keum Won KIM ; Ji Hyung KIM
Journal of the Korean Radiological Society 2006;55(2):143-148
PURPOSE: When pneumothorax occurs during a percutaneous needle biopsy, the radiologist usually stops the biopsy. We evaluated the usefulness of computed tomographic (CT) fluoroscopy-guided percutaneous needle biopsy in the presence of pneumothorax during biopsy. MATERIALS AND METHODS: We performed 288 CT fluoroscopy guided percutaneous needle biopsies to diagnose the pulmonary nodules. Twenty two of these patients had pneumothorax that occurred during the biopsy without obtaining an adequate specimen. After pneumothoax occurred, we performed immediate CT fluoroscopy guided percutaneous needle biopsies using an 18-gauge cutting needle. We evaluated the success rate of the biopsies and also whether or not the pneumothorax progressed. We classified these patients into two groups according to whether the pneumothorax progressed (Group 2) or not (Group 1) by measuring the longest distance between the parietal pleura and the visceral pleura both in the early and late pneumothorax. Additionally, we analyzed the relationship between the progression of pneumothorax after biopsy and 1) the depth of the pulmonary nodule; 2) the number of biopsies; 3) the presence or absence of emphysema at the biopsy site; and 4) the size of the pulmonary nodule. RESULTS: Biopsy was successful in 19 of 22 nodules (86.3%). Of the 19 nodules, 12 (63.2%) were malignant and 7 (36.8%) were benign. Twelve patients (54.5%) were classified as group 1 and 10 patients (45.4%) as group 2. The distance between the lung lesion and pleura showed a statistically significant difference between these two groups: < or = 1 cm in distance for group 1 (81.8%) and group 2 (18.2%), and > 1 cm in distance for group 1 (30%) and group 2 (70%), p < 0.03. Yet the number of biopsies, the presence or absence of emphysema at the biopsy site and the size of the pulmonary nodules were not related to the progression of pneumothorax (p > 0.05). CONCLUSION: When early pneumothorax occurs during a biopsy, CT fluoroscopy guided percutaneous needle biopsy is an effective and safe procedure. Aggravation of pneumothorax after biopsy is affected by the depth of the pulmonary nodule.
Biopsy*
;
Biopsy, Needle*
;
Emphysema
;
Fluoroscopy
;
Humans
;
Lung
;
Needles*
;
Pleura
;
Pneumothorax*
5.Biliary Ascariasis: MR Cholangiography Findings in Two Cases.
Cheol Mok HWANG ; Tae Kyoung KIM ; Hyun Kwon HA ; Pyo Nyun KIM ; Moon Gyu LEE
Korean Journal of Radiology 2001;2(3):175-178
We describe the imaging features of two cases of biliary ascariasis. Ultrasonography and CT showed no specific abnormal findings, but MR cholangiography clearly demonstrated an intraductal linear filling defect that led to the correct diagnosis. MR cholangiography is thus a useful technique for the diagnosis of biliary ascariasis.
Adult
;
Animal
;
Ascariasis/*diagnosis
;
*Ascaris lumbricoides
;
*Bile Ducts, Intrahepatic
;
Biliary Tract Diseases/*diagnosis/*parasitology
;
Common Bile Duct Diseases/*diagnosis/*parasitology
;
Female
;
Human
;
*Magnetic Resonance Imaging
6.The Diagnostic Usefulness of CT-guided Needle Biopsy or Aspiration in Infectious Spondylitis.
Cheol Mok HWANG ; Myung Jin SHIN ; Sung Moon KIM ; Sang Hoon LEE ; Sang Min LEE ; Ji Hoon SHIN ; Soon Tae KWON ; Sang Jin BAE
Journal of the Korean Radiological Society 2003;48(6):497-504
PURPOSE: To determine the diagnostic value of CT-guided biopsy or aspiration of the spine and paraspinal soft tissue in infectious spondylitis. MATERIALS AND METHODS: Between January 2000 and June 2002, 58 patients underwent 67 biopsies and/or aspirations under CT guidance to identify the organism causing infectious spondylitis, and were included in this study. Nine underwent rebiopsy. In all patients, MR images were available before biopsy and/or aspiration. In 63 of 67 procedures, the specimens or aspirates obtained were prepared for culture and smear, and for histological examination, four procedures involved aspiration only. In ten patients with suspected tuberculosis, a polymerase chain reaction test was performed. For all procedures, the transpedicular, transcostovertebral or paravertebral route was involved, according to the level and shape of the lesions, and 14-, 16-, or 18-gauge core biopsy needles and/or 20-gauge aspiration needles were employed. Lesions invloved a paravertebral (n=17), psoas (n=8) or epidural (n=1) abscess; an intervertebral disc (n=20); or a vertebral body (n=21). The levels at the mid-thoracic spine were T4-T10 (n=11); at the thoracolumbar junction, T11-L1 (n=14); at the lumbar spine, L1-L4 (n=25); and at the lumbo-sacral junction, L5-S1 (n=17). In nine of 58 patients, rebiopsy was performed. RESULTS: Diagnosis was confirmed in 22 of 58 patients (38%), and was as follows: tuberculous spondylitis (n=17), pyogenic spondylitis (n=4), and fungal spondylitis (n=1). Thirty-six unconfirmed cases were diagnosed as nonspecific inflammation (n=21), fibrosis involving cortical bone (n=1), necrotic material (n=5) and inadequate specimen without evidence of malignancy (n=9). Only one of the nine cases in which biopsy was repeated was confirmed as tuberculous spondylitis. Diagnosis was confirmed in 7 of 17 paravertebral abscesses (41%), 8 of 21 vertebral bodies (38%), 6 of 20 intervertebral discs (30%) and 1 of 8 psoas abscesses (13%). CONCLUSION: In infectious spondylitis, the overall diagnostic yield of CT-guided needle biopsy and/or aspiration is relatively low, but the procedure seems to be effective for excluding malignancy. In identifying the organisms involved in infectious spondylitis, a paravertebral lesion is in a more favoured location than a psoas lesion.
Abscess
;
Aspirations (Psychology)
;
Biopsy
;
Biopsy, Needle*
;
Diagnosis
;
Fibrosis
;
Humans
;
Inflammation
;
Intervertebral Disc
;
Needles*
;
Polymerase Chain Reaction
;
Psoas Abscess
;
Spine
;
Spondylitis*
;
Tuberculosis
7.A Case about Use of Mycophenolate Mofetil in Acute Renal Failure Associated with Lupus Nephritis.
Mi Jeong PARK ; Hyun Ju KIM ; Hwa Mok LEE ; Joon Seok OH ; Hyun Cheol HWANG ; Dong Han IM ; Hoe Joo OH ; Yong Ki PARK ; Yong Hun SHIN ; Joong Kyung KIM
Korean Journal of Nephrology 2006;25(4):635-639
Mycophenolate mofetil (MMF) is a immunosuppressive agent increasingly used in organ transplantation and autoimmune disease. We report a case about use of MMF in SLE patient with rapidly worsening renal function. A 24-year old female was admitted due to 1-week history of generalized edema. Despite use of diuretics and conventional supported care, generalized edema was more aggravated and serum creatinine was elevated up to 5.2 mg/dL. Ten days after the initial admission, we started hemodialysis. After hemodialysis, improvement of generalized edema was achieved. Eighteen days after initial hemodialysis, we started corticosteroids and MMF because she shows persistent heavy proteinuria and oliguria. After use of corticosteroids and MMF, clinical improvement of renal complication was achieved in this patient. About 6 weeks later, we could discontinue hemodialysis. On two year follow up duration, she shows good renal function and no evidence of lupus flare-up signs. We suggest MMF is one of therapeutic options for patients with severe lupus nephritis, especially those refractory or intolerant to conventional cytotoxic agents.
Acute Kidney Injury*
;
Adrenal Cortex Hormones
;
Autoimmune Diseases
;
Creatinine
;
Cytotoxins
;
Diuretics
;
Edema
;
Female
;
Follow-Up Studies
;
Humans
;
Lupus Nephritis*
;
Oliguria
;
Organ Transplantation
;
Proteinuria
;
Renal Dialysis
;
Transplants
;
Young Adult
8.Desmoplastic Small Round Cell Tumor Achieved Complete Remission after High-Dose Chemotherapy with Aggressive Local Treatment Modalities.
Sun Mok KIM ; Ji Hyun PARK ; Jung Seok KIM ; Min Soo KIM ; Jung Eun JANG ; Hee Sang HWANG ; Cheol Won SUH
Korean Journal of Medicine 2012;83(3):378-384
A desmoplastic small-round-cell tumor (DSRCT) is a rare, aggressive neoplasm that develops mostly in the abdominal cavity in children and young adults. We present a case of a 19-year-old male with right upper quadrant discomfort for 3 months. On abdominal computerized tomography, multiple huge and demarcated masses were found in the liver, retroperitoneal lymph nodes, and peritoneal and retroperitoneal cavities. Fine needle aspiration biopsy of the hepatic mass was performed and DSRCT was diagnosed by hematoxylin and eosin staining and immunohistochemical analysis. He was treated initially with high-dose systemic chemotherapy (alternating schedules of cyclophosphamide, vincristine, doxorubicin, ifosfamide, and etoposide), underwent two debulking surgeries and pelvic irradiation between systemic chemotherapy schedules, and achieved complete remission after the 15 months of treatment duration. We report this case to emphasize the importance of aggressive local treatment modalities as well as high-dose systemic chemotherapy for treatment of DSRCT even with initially unresectable or extensively metastatic presentation.
Abdominal Cavity
;
Appointments and Schedules
;
Biopsy
;
Biopsy, Fine-Needle
;
Child
;
Cyclophosphamide
;
Desmoplastic Small Round Cell Tumor
;
Doxorubicin
;
Eosine Yellowish-(YS)
;
Hematoxylin
;
Humans
;
Ifosfamide
;
Liver
;
Lymph Nodes
;
Male
;
Vincristine
;
Young Adult
9.Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline.
Yong Il HWANG ; Yong Bum PARK ; Yeon Mok OH ; Ji Hyun LEE ; Tae Hyung KIM ; Kwang Ha YOO ; Hyoung Kyu YOON ; Chin Kook RHEE ; Deog Kyeom KIM ; Kyeong Cheol SHIN ; Sang Yeub LEE ; Ki Suck JUNG
Journal of Korean Medical Science 2014;29(8):1108-1112
The purpose of this study was to compare the Korean COPD guideline to GOLD consensus report in terms of acute exacerbation. A total of 361 patients were enrolled in this study, and 16.9% of them experienced acute exacerbation during the follow-up. A total of 6.3% of patients in GOLD A, 9.5% in GOLD B, 7.7% in GOLD C and 17.0% of GOLD D experienced exacerbation during the first year of follow-up, respectively (P=0.09). There was no one who experienced exacerbation during the first year of follow-up in the Korean group 'ga'. The 12-month exacerbation rates of Korean group 'na' and 'da' were 4.5% and 16.0%, respectively (P<0.001). We explore the experience of exacerbation in patients with change of their risk group after applying Korean COPD guideline. A total of 16.0% of the patients who were reclassified from GOLD A to Korean group 'da' experienced acute exacerbation,and 15.3% from GOLD B to Korean group 'da' experienced acute exacerbation. In summary, the Korean COPD guideline is useful to differentiate the high risk from low risk for exacerbation in terms of spirometry. This indicates that application of Korean COPD guideline is appropriate to treat Korean COPD patients.
Acute Disease
;
Aged
;
Disease Progression
;
Female
;
Humans
;
Male
;
*Practice Guidelines as Topic
;
Pulmonary Disease, Chronic Obstructive/*classification/*diagnosis
;
Pulmonary Medicine/*standards
;
Reproducibility of Results
;
Republic of Korea
;
Sensitivity and Specificity
;
*Severity of Illness Index
;
Spirometry/*standards
10.The clinical outcome of renal transplantation with a poor HLA matched living kidney donors.
Yong Hun SIN ; Hyun Ju KIM ; Hwa Mok LEE ; Joon Seok OH ; Hyun Cheol HWANG ; Dong Han IM ; Ji Hwan KIM ; Chang Soo PARK ; Mi Jeong PARK ; Hoe Joo OH ; Yong Ki PARK ; Joong Kyung KIM ; Gun Ung JEON
Korean Journal of Medicine 2005;69(4):402-409
BACKGROUND: Poor HLA matched donors may become an additional organ source for renal transplantation. This study is conducted to predict the clinical outcomes of renal transplantation in a poor HLA matched group (0 or 1 or 2 HLA matching) by comparing them with those of HLA haploidentical group. METHODS: This study compared a poor HLA matched group (N=89) with HLA haploidentical group (N=79) to analyze differences between two groups in graft survival, incidence of acute rejection, cause of graft failure, posttransplant serum creatinine at 1, 2, 3, 5 years. Total 168 cases, appeared in the medical records for more than six months in Bong-Saeng Hospital, from December, 1984 to March, 2004 were traced and identified as relevant cases for this study. RESULTS: Allograft survival rate at 1, 3, 5, 10 years for poor HLA matched group and HLA haploidentical group were 100%, 98.6%, 95.4%, 72.5% and 100%, 100%, 96.1%, 86.2% (p=not significant) respectively. Acute rejection developed in 25.8% of poor HLA matched group versus 18.9% of HLA haploidentical group (p=not significant). The most common causes of graft failure in both groups were chronic rejection. CONCLUSIONS: It should be actively encouraged to consider renal transplantation in a poor HLA matched group as the results of this study support that the clinical outcomes of renal transplantation in a poor HLA matched group are equivalent to those of HLA haploidentical group.
Allografts
;
Creatinine
;
Graft Survival
;
Humans
;
Incidence
;
Kidney Transplantation*
;
Kidney*
;
Medical Records
;
Research Design
;
Survival Rate
;
Tissue Donors*
;
Transplants